Treatment of Helicobacter pylori

被引:20
作者
Hoffman, JS [1 ]
Cave, DR [1 ]
机构
[1] St Elizabeths Med Ctr, Div Gastroenterol, Brighton, MA 02135 USA
关键词
D O I
10.1097/00001574-200101000-00006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori causes several gastroduodenal diseases. Various antibiotic regimens are available that eradicate H. pylori in 80 to 90% of patients, but no regimen cures all patients. Dual therapy is now obsolete. Triple therapy with two antibiotics and either a proton pump inhibitor or bismuth is the regimens of choice. Metronidazole and clarithromycin are the two key antibiotics. Antibiotic resistance against these two drugs is becoming more problematic and should be taken into consideration when choosing a regimen, Antibiotic resistance is usually induced after failure. Quadruple therapy has been used as a salvage regimen in failed cases but it is also the most complicated regimen. Several new agents are being studied including a single capsule that contains bismuth, metronidazole, and tetracycline. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 34 条
[31]  
Sharma VK, 1999, AM J GASTROENTEROL, V94, P3170, DOI 10.1111/j.1572-0241.1999.01512.x
[32]  
Sieg A, 1999, ALIMENT PHARM THER, V13, P865
[33]   One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection:: the RBC-MACH study [J].
Sung, JJY ;
Chan, FKL ;
Wu, JCY ;
Leung, WK ;
Suen, R ;
Ling, TKW ;
Lee, YT ;
Cheng, AFB ;
Chung, SCS .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (08) :1079-1084
[34]   Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation [J].
Trebesius, K ;
Panthel, K ;
Strobel, S ;
Vogt, K ;
Faller, G ;
Kirchner, T ;
Kist, M ;
Heesemann, J ;
Haas, R .
GUT, 2000, 46 (05) :608-614